Literature DB >> 31611666

LEAP2: A novel regulator of food intake and body weight?

Martha A Schalla1, Andreas Stengel2,3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31611666     DOI： 10.1038/s41575-019-0224-9

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  3 in total

Review 1.  Recent progress in the discovery of ghrelin O-acyltransferase (GOAT) inhibitors.

Authors:  Malliga R Iyer; Casey M Wood; George Kunos
Journal:  RSC Med Chem       Date:  2020-09-04

Review 2.  LEAP-2: An Emerging Endogenous Ghrelin Receptor Antagonist in the Pathophysiology of Obesity.

Authors:  Xuehan Lu; Lili Huang; Zhengxiang Huang; Dandan Feng; Richard J Clark; Chen Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-24       Impact factor: 5.555

3.  Serum levels of ghrelin and LEAP2 in patients with type 2 diabetes mellitus: correlation with circulating glucose and lipids.

Authors:  Jiaxi Li; Pu Huang; Jing Xiong; Xinyue Liang; Mei Li; Hao Ke; Chunli Chen; Yang Han; Yanhong Huang; Yan Zhou; Ziqiang Luo; Dandan Feng; Chen Chen
Journal:  Endocr Connect       Date:  2022-05-27       Impact factor: 3.221
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.